|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
EP1165508B1
(en)
|
1999-04-07 |
2004-06-23 |
The University of Virginia Patent Foundation |
Anticancer calcium channel blockers
|
|
JP2005511743A
(ja)
|
2001-12-13 |
2005-04-28 |
ウォックハート・リミテッド |
新世代の三重標的化したキラルな広域スペクトラム抗菌性の７位置換ピペリジノ−キノロンカルボン酸誘導体、その調製方法、組成物、および医薬としての使用
|
|
US6900224B2
(en)
|
2002-07-31 |
2005-05-31 |
The Procter & Gamble Company |
Antimicrobial quinolones, their compositions and uses
|
|
PL1633724T3
(pl)
|
2003-03-12 |
2011-10-31 |
Kudos Pharm Ltd |
Pochodne ftalazynonu
|
|
US7531530B2
(en)
|
2003-07-25 |
2009-05-12 |
Cancer Research Technology Limited |
Therapeutic compounds
|
|
US20050118291A1
(en)
|
2003-09-10 |
2005-06-02 |
Mian-Ying Wang |
Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane
|
|
WO2005033108A1
(en)
|
2003-09-22 |
2005-04-14 |
Janssen Pharmaceutica, N.V. |
7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
|
|
PL2305221T3
(pl)
|
2003-12-01 |
2015-11-30 |
Kudos Pharm Ltd |
Inhibitory naprawy uszkodzeń DNA w leczeniu raka
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
WO2006034113A2
(en)
|
2004-09-17 |
2006-03-30 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs as cell proliferation inhibitors
|
|
US7816524B2
(en)
|
2005-08-05 |
2010-10-19 |
Cylene Pharmaceuticals, Inc. |
Methods of preparing quinolone analogs
|
|
JP2009504192A
(ja)
|
2005-08-19 |
2009-02-05 |
サイリーン ファーマシューティカルズ インコーポレーティッド |
ヒトリボソームＤＮＡ（ｒＤＮＡ）およびリボソームＲＮＡ（ｒＲＮＡ）核酸ならびにそれらの使用
|
|
AR057555A1
(es)
|
2005-10-27 |
2007-12-05 |
Merck Frosst Canada Ltd |
Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
|
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
|
EP2023720A4
(en)
|
2006-05-17 |
2009-06-10 |
Cylene Pharmaceuticals Inc |
TETRACYCLIC IMIDAZOLE ANALOG
|
|
WO2007146813A2
(en)
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs as cell proliferation inhibitors
|
|
WO2007146831A2
(en)
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
GB0701992D0
(en)
|
2007-02-02 |
2007-03-14 |
7Tm Pharma As |
Grehlin Receptor Modulators
|
|
US20110065687A1
(en)
|
2007-04-17 |
2011-03-17 |
Michael Schwaebe |
Hydrazide compounds and uses thereof
|
|
US7928100B2
(en)
|
2007-10-05 |
2011-04-19 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs and methods related thereto
|
|
AU2008201871A1
(en)
|
2008-04-16 |
2009-11-26 |
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts |
Inhibition of angiogenesis and tumor metastasis
|
|
US9359605B2
(en)
|
2011-03-11 |
2016-06-07 |
Sarissa Inc. |
Method of treating cancer by inhibition of DNA repair proteins
|
|
US20140086839A1
(en)
*
|
2011-03-17 |
2014-03-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
|
WO2013133876A1
(en)
|
2011-12-07 |
2013-09-12 |
The Regents Of The University Of California |
Biomarkers for prediction of response to parp inhibition in breast cancer
|
|
US9044421B2
(en)
|
2012-03-28 |
2015-06-02 |
Genus Oncology, Llc |
Treating MUC1-expressing cancers with combination therapies
|
|
HK1203971A1
(en)
|
2012-05-15 |
2015-11-06 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
|
|
US20160145355A1
(en)
|
2013-06-24 |
2016-05-26 |
Biomed Valley Discoveries, Inc. |
Bispecific antibodies
|
|
ES2754207T3
(es)
*
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
|
KR102410090B1
(ko)
|
2014-02-21 |
2022-06-16 |
넥타르 테라퓨틱스 (인디아) 프라이빗 리미티드 |
항-ｃｔｌａ－４ 항체 또는 항-ｐｄ－１ 항체와 조합한 ｉｌ－２ｒ베타-선택적 효현제
|
|
JP7017509B2
(ja)
|
2015-11-20 |
2022-02-08 |
センワ バイオサイエンシズ インコーポレイテッド |
がんを治療するための四環式キノロン類似体の併用療法
|
|
JP2018537486A
(ja)
*
|
2015-12-14 |
2018-12-20 |
センワ バイオサイエンシズ インコーポレイテッド |
キノロン類似体及びその塩の結晶形
|
|
US9957282B2
(en)
*
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
WO2017100925A1
(en)
|
2015-12-15 |
2017-06-22 |
British Columbia Cancer Agency Branch |
Metal complexed therapeutic agents and lipid-based nanoparticulate formulations thereof
|
|
WO2017205832A1
(en)
*
|
2016-05-26 |
2017-11-30 |
Fred Hutchinson Cancer Research Center |
L-myc pathway targeting as a treatment for small cell lung cancer
|
|
CN112334133A
(zh)
|
2018-02-15 |
2021-02-05 |
生华生物科技股份有限公司 |
喹诺酮类似物及其盐、组合物及其使用方法
|
|
EP4013421A4
(en)
|
2019-08-14 |
2023-08-23 |
Senhwa Biosciences, Inc. |
TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS AND METHODS OF USE
|
|
CA3151116A1
(en)
|
2019-08-14 |
2021-02-18 |
Hshiou-Ting Liu |
Crystalline forms of quinoline analogs and salts thereof, compositions, and their methods for use
|
|
US20220062294A1
(en)
|
2020-09-02 |
2022-03-03 |
Senhwa Biosciences, Inc. |
Pharmaceutical compositions of tetracyclic quinolone analogs and their salts
|